Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

Abin-1 Inhibitors

The class of compounds referred to as Abin-1 inhibitors encompasses a group of chemical agents that are specifically designed to modulate the activity of the Abelson interactor 1 (Abin-1) protein. Abin-1 is a critical regulator of cellular signaling pathways, playing a pivotal role in processes such as cellular adhesion, proliferation, and migration. Abin-1 is particularly noteworthy due to its interaction with the Abl-1 kinase, a key player in various cellular functions. In this context, Abin-1 inhibitors exert their effects by interfering with the interaction between Abin-1 and Abl-1 kinase, leading to downstream effects on various cellular processes. Structurally, Abin-1 inhibitors exhibit a diverse range of chemical compositions. These compounds are meticulously designed to bind to specific sites on Abin-1, disrupting its functional interaction with Abl-1 kinase.

One common mechanism involves the inhibition of Abin-1's ability to associate with Abl-1 through competition for binding sites. This interference subsequently leads to the modulation of the signaling pathways regulated by Abl-1, which are integral to fundamental cellular behaviors. In some cases, Abin-1 inhibitors may operate through allosteric mechanisms, inducing conformational changes in Abin-1 that hinder its interaction with Abl-1 kinase. The development and study of Abin-1 inhibitors hold significant promise for advancing our understanding of cellular signaling cascades and their intricate regulation. By specifically targeting the Abin-1 and Abl-1 interaction, researchers aim to decipher the intricate interplay between these proteins and their downstream effects. This class of inhibitors presents a valuable tool for investigating the mechanistic underpinnings of cellular processes that are intricately associated with Abin-1's functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Binds to the ATP-binding site of Abl-1, inhibiting its kinase activity; used for chronic myeloid leukemia and certain other cancers.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Binds to the ATP-binding site of Abl-1 and other kinases, inhibiting their activity; indicated for various types of leukemia.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Selectively inhibits the kinase activity of Abl-1 by targeting its ATP-binding site; used for chronic myeloid leukemia.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$175.00
$983.00
2
(1)

Targets the ATP-binding domain of Abl-1, inhibiting its kinase activity; used for resistant forms of chronic myeloid leukemia.

Bcr-abl Inhibitor

778270-11-4sc-203836
5 mg
$149.00
1
(0)

Allosteric inhibitor that binds outside the ATP-binding pocket of Abl-1, causing conformational changes that lead to inhibition.